DEF: GeneDx Holdings Corp. Announces 2025 Annual Meeting of Stockholders

GeneDx Holdings Corp. will hold its 2025 annual meeting of stockholders virtually on June 18, 2025, to elect directors and ratify the appointment of its independent auditor.

Summary

• GeneDx Holdings Corp. is holding its 2025 annual meeting of stockholders on June 18, 2025, at 9:00 a.m. Eastern Time, via a virtual meeting.
• Stockholders of record as of April 21, 2025, are entitled to vote.
• The meeting will address the election of two Class I directors to serve until the 2028 annual meeting, the ratification of Ernst & Young LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2025, and any other business that may properly come before the meeting.
• The Board of Directors recommends voting FOR the election of the director nominees and FOR the ratification of Ernst & Young LLP.
• Proxy materials were first distributed on or about April 30, 2025.
• The company's Class A Common Stock outstanding and entitled to vote as of April 21, 2025, was 28,533,204 shares.

Sentiment

Score: 7

Explanation: The document is a standard proxy statement, which is generally neutral in tone. It provides factual information about the company and the proposals to be voted on at the annual meeting. The sentiment is slightly positive due to the Board's recommendations to vote in favor of the proposals and the inclusion of positive corporate governance practices.

Positives

• The company is using a virtual meeting format to provide greater access to stockholders.
• The Board has adopted stock ownership guidelines to align the interests of directors and officers with those of stockholders.
• The Board has determined that each member of the Audit Committee is financially literate.
• The company has a clawback policy in place regarding the adjustment or recovery of certain incentive awards or payments made to current or former executive officers.

Future Outlook

The document outlines the proposals to be voted on at the 2025 annual meeting and provides information to stockholders to assist them in making informed voting decisions.

Management Comments

• On behalf of our Board, I would like to thank you for your support of GeneDx Holdings Corp.
• The Board recommends that you vote FOR each of these proposals.

Industry Context

This is a standard proxy statement for a publicly traded company, outlining the matters to be voted on at the annual meeting and providing information about the company's corporate governance practices, executive compensation, and related party transactions.

Comparison to Industry Standards

• The corporate governance practices described in the proxy statement, such as having an audit committee, compensation committee, and nominating and corporate governance committee, are standard for publicly traded companies.
• The director compensation structure, including cash retainers and equity grants, is also typical for companies of similar size and complexity.
• The company's clawback policy and insider trading policy are in line with regulatory requirements and best practices.

Corporate Governance

Related Party Transactions

• The company has engaged in related party transactions with entities affiliated with directors and significant stockholders, including purchases of stock in underwritten and registered direct offerings, transition services agreements, and commercial relationships.
• The company has a written related party transaction policy in place that requires Audit Committee approval for any related-party transaction exceeding $120,000.

Stakeholder Impact

• The proposals to be voted on at the annual meeting, including the election of directors and the ratification of the auditor, will impact the governance and oversight of the company, which affects all stakeholders.
• The executive compensation program and director compensation policy impact the alignment of management and director interests with those of stockholders.
• Related party transactions are subject to review and approval to ensure fairness and transparency for all stakeholders.

Next Steps

• Stockholders are encouraged to submit their proxies and voting instructions via the Internet, by telephone, or by mail.
• Stockholders can attend and vote at the Annual Meeting online by visiting www.virtualshareholdermeeting.com/wgs2025 and using a control number assigned by Continental Stock Transfer & Trust Company.

Key Dates

Keywords

annual meeting, proxy statement, directors, auditor, stockholders, corporate governance, executive compensation, GeneDx